Factors associated with COVID-19 vaccine hesitancy after implementation of a mass vaccination campaign

Bibliographic Details
Main Author: Gomes, Inês Afonso
Publication Date: 2022
Other Authors: Soares, Patricia, Rocha, João Victor, Gama, Ana, Laires, Pedro Almeida, Moniz, Marta, Pedro, Ana Rita, Dias, Sónia, Goes, Ana Rita, Leite, Andreia, Nunes, Carla
Format: Article
Language: eng
Source: Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
Download full: http://hdl.handle.net/10362/137474
Summary: Funding Information: Funding: The present publication was funded by Fundação Ciência e Tecnologia, IP national support through CHRC (UIDP/04923/2020). Publisher Copyright: © 2022 by the authors. Licensee MDPI, Basel, Switzerland.
id RCAP_43bcc8dbe1d7a5bc6c7272d97da3cfd2
oai_identifier_str oai:run.unl.pt:10362/137474
network_acronym_str RCAP
network_name_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository_id_str https://opendoar.ac.uk/repository/7160
spelling Factors associated with COVID-19 vaccine hesitancy after implementation of a mass vaccination campaignCOVID-19VaccinationVaccine hesitancyImmunologyPharmacologyDrug DiscoveryInfectious DiseasesPharmacology (medical)SDG 3 - Good Health and Well-beingFunding Information: Funding: The present publication was funded by Fundação Ciência e Tecnologia, IP national support through CHRC (UIDP/04923/2020). Publisher Copyright: © 2022 by the authors. Licensee MDPI, Basel, Switzerland.An online cross-sectional study on COVID-19 vaccination adhesion was conducted in Portugal nine months after vaccination rollout (September–November 2021). Logistic regression was used to identify factors associated with hesitancy to take the COVID-19 vaccine in the communitybased survey, “COVID-19 Barometer: Social Opinion”. Hesitancy was 11%; however, of those, 60.5% stated that they intended to take the vaccine. Hesitancy was associated with factors such as lower monthly household income; no intention of taking the flu vaccine this year; perceived reasonable health status; having two or more diseases; low confidence in the health service response; worse perception of the adequacy of anti-COVID-19 government measures; low or no perceived risk of getting COVID-19; feeling agitated, anxious or sad some days; and lack of trust in the safety and efficacy of the vaccines. Confidence in vaccines, namely against COVID-19, is paramount for public health and should be monitored during vaccination rollout. Clear communication of the risks and benefits of vaccination needs improvement to increase adherence and public confidence.Comprehensive Health Research Centre (CHRC) - Pólo ENSPCentro de Investigação em Saúde Pública (CISP/PHRC)Escola Nacional de Saúde Pública (ENSP)RUNGomes, Inês AfonsoSoares, PatriciaRocha, João VictorGama, AnaLaires, Pedro AlmeidaMoniz, MartaPedro, Ana RitaDias, SóniaGoes, Ana RitaLeite, AndreiaNunes, Carla2022-05-05T22:36:14Z2022-022022-02-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10362/137474engPURE: 43707635https://doi.org/10.3390/vaccines10020281info:eu-repo/semantics/openAccessreponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAP2024-05-22T18:01:21Zoai:run.unl.pt:10362/137474Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-28T17:32:18.251165Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse
dc.title.none.fl_str_mv Factors associated with COVID-19 vaccine hesitancy after implementation of a mass vaccination campaign
title Factors associated with COVID-19 vaccine hesitancy after implementation of a mass vaccination campaign
spellingShingle Factors associated with COVID-19 vaccine hesitancy after implementation of a mass vaccination campaign
Gomes, Inês Afonso
COVID-19
Vaccination
Vaccine hesitancy
Immunology
Pharmacology
Drug Discovery
Infectious Diseases
Pharmacology (medical)
SDG 3 - Good Health and Well-being
title_short Factors associated with COVID-19 vaccine hesitancy after implementation of a mass vaccination campaign
title_full Factors associated with COVID-19 vaccine hesitancy after implementation of a mass vaccination campaign
title_fullStr Factors associated with COVID-19 vaccine hesitancy after implementation of a mass vaccination campaign
title_full_unstemmed Factors associated with COVID-19 vaccine hesitancy after implementation of a mass vaccination campaign
title_sort Factors associated with COVID-19 vaccine hesitancy after implementation of a mass vaccination campaign
author Gomes, Inês Afonso
author_facet Gomes, Inês Afonso
Soares, Patricia
Rocha, João Victor
Gama, Ana
Laires, Pedro Almeida
Moniz, Marta
Pedro, Ana Rita
Dias, Sónia
Goes, Ana Rita
Leite, Andreia
Nunes, Carla
author_role author
author2 Soares, Patricia
Rocha, João Victor
Gama, Ana
Laires, Pedro Almeida
Moniz, Marta
Pedro, Ana Rita
Dias, Sónia
Goes, Ana Rita
Leite, Andreia
Nunes, Carla
author2_role author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Comprehensive Health Research Centre (CHRC) - Pólo ENSP
Centro de Investigação em Saúde Pública (CISP/PHRC)
Escola Nacional de Saúde Pública (ENSP)
RUN
dc.contributor.author.fl_str_mv Gomes, Inês Afonso
Soares, Patricia
Rocha, João Victor
Gama, Ana
Laires, Pedro Almeida
Moniz, Marta
Pedro, Ana Rita
Dias, Sónia
Goes, Ana Rita
Leite, Andreia
Nunes, Carla
dc.subject.por.fl_str_mv COVID-19
Vaccination
Vaccine hesitancy
Immunology
Pharmacology
Drug Discovery
Infectious Diseases
Pharmacology (medical)
SDG 3 - Good Health and Well-being
topic COVID-19
Vaccination
Vaccine hesitancy
Immunology
Pharmacology
Drug Discovery
Infectious Diseases
Pharmacology (medical)
SDG 3 - Good Health and Well-being
description Funding Information: Funding: The present publication was funded by Fundação Ciência e Tecnologia, IP national support through CHRC (UIDP/04923/2020). Publisher Copyright: © 2022 by the authors. Licensee MDPI, Basel, Switzerland.
publishDate 2022
dc.date.none.fl_str_mv 2022-05-05T22:36:14Z
2022-02
2022-02-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10362/137474
url http://hdl.handle.net/10362/137474
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv PURE: 43707635
https://doi.org/10.3390/vaccines10020281
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron:RCAAP
instname_str FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron_str RCAAP
institution RCAAP
reponame_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
collection Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository.name.fl_str_mv Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
repository.mail.fl_str_mv info@rcaap.pt
_version_ 1833596768947798016

Similar Items